Stay updated on Nivolumab and Cyclophosphamide for R/R AML Clinical Trial

Sign up to get notified when there's something new on the Nivolumab and Cyclophosphamide for R/R AML Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab and Cyclophosphamide for R/R AML Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Difference
    0.7%
    Check dated 2025-05-07T01:14:51.000Z thumbnail image
  2. Check
    9 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.
    Difference
    1.0%
    Check dated 2025-04-30T00:00:41.000Z thumbnail image
  3. Check
    16 days ago
    Change Detected
    Summary
    The page has undergone significant content changes, including the removal of detailed information about a clinical trial for nivolumab and low dose cyclophosphamide, while adding a new identifier related to the University of Minnesota's Division of Hematology, Oncology and Transplantation.
    Difference
    26%
    Check dated 2025-04-22T18:12:52.000Z thumbnail image
  4. Check
    24 days ago
    Change Detected
    Difference
    0.4%
    Check dated 2025-04-15T14:01:07.000Z thumbnail image
  5. Check
    31 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.14.3 to version 2.14.4.
    Difference
    0.8%
    Check dated 2025-04-08T09:06:31.000Z thumbnail image
  6. Check
    38 days ago
    Change Detected
    Summary
    The page has been updated to include information on Acute Myeloid Leukemia while removing references to Myelodysplastic Syndromes.
    Difference
    0.2%
    Check dated 2025-04-01T04:44:29.000Z thumbnail image

Stay in the know with updates to Nivolumab and Cyclophosphamide for R/R AML Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab and Cyclophosphamide for R/R AML Clinical Trial page.